Nexalin Technology (NXL) EBIAT (2021 - 2025)
Nexalin Technology (NXL) has 5 years of EBIAT data on record, last reported at -$2.3 million in Q3 2025.
- For Q3 2025, EBIAT rose 7.02% year-over-year to -$2.3 million; the TTM value through Sep 2025 reached -$8.7 million, down 56.25%, while the annual FY2024 figure was -$7.6 million, 63.64% down from the prior year.
- EBIAT reached -$2.3 million in Q3 2025 per NXL's latest filing, down from -$1.6 million in the prior quarter.
- Across five years, EBIAT topped out at -$135401.0 in Q3 2022 and bottomed at -$2.8 million in Q4 2024.
- Average EBIAT over 5 years is -$1.3 million, with a median of -$1.0 million recorded in 2024.
- Peak YoY movement for EBIAT: soared 92.48% in 2022, then plummeted 1596.58% in 2023.
- A 5-year view of EBIAT shows it stood at -$577489.0 in 2021, then dropped by 26.35% to -$729677.0 in 2022, then fell by 6.99% to -$780669.0 in 2023, then crashed by 262.93% to -$2.8 million in 2024, then increased by 19.66% to -$2.3 million in 2025.
- Per Business Quant database, its latest 3 readings for EBIAT were -$2.3 million in Q3 2025, -$1.6 million in Q2 2025, and -$2.0 million in Q1 2025.